Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:28 PM EST
352.03quote price arrow down-0.40 (-0.11%)
Volume
1,001,734
Close
352.43quote price arrow down-16.08 (-4.36%)
Volume
23,081,521
52 week range
102.66 - 497.49
Loading...
  • Open351.58
  • Day High357.64
  • Day Low337.29
  • Prev Close368.51
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap142.258B
  • Shares Out403.65M
  • 10 Day Average Volume13.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change237.35

KEY STATS

  • Open351.58
  • Day High357.64
  • Day Low337.29
  • Prev Close368.51
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20
  • Market Cap142.258B
  • Shares Out403.65M
  • 10 Day Average Volume13.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change237.35

RATIOS/PROFITABILITY

  • EPS (TTM)16.28
  • P/E (TTM)21.64
  • Fwd P/E (NTM)8.01
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date02/23/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:0004:00
Uncertainty around vaccine effectiveness points to a slowdown, says Jim Cramer

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
351.74-10.78-2.97%
REGN
Regeneron Pharmaceuticals Inc
636.53-17.87-2.73%
BIIB
Biogen Inc
235.74-0.37-0.16%
ILMN
Illumina Inc
365.33-5.48-1.48%
SYNH
Syneos Health Inc
97.16-2.83-2.83%